keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Lanreotide acetate (BIM 23014 acetate) is a somatostatin analogue with antineoplastic activity, used for carcinoid syndrome
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 37.00 | |
5 mg | In stock | $ 59.00 | |
10 mg | In stock | $ 97.00 | |
25 mg | In stock | $ 176.00 | |
50 mg | In stock | $ 262.00 | |
100 mg | In stock | $ 389.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 133.00 |
Description | Lanreotide acetate (BIM 23014 acetate) is a somatostatin analogue with antineoplastic activity, used for carcinoid syndrome |
In vivo | In a mouse GH3 tumor xenograft model, lanreotide 10 mg/kg moderately inhibited the growth of GH3 tumors, with a 4x tumor growth delay (TGD) time that ranged from 4.5 to 8.3 days. Fractionated local tumor radiation alone significantly inhibited tumor growth and produced a TGD of 35.1+/-5.7 days for 250 cGy fractions[1]. |
Animal Research | Animal Model:Male nude mice, 8 weeks old and 20–25?g in body weight (GH3 tumor-bearing nude mice).Dosage: 2.5, 5, 10?mg/kg. Administration:Subcutaneous; daily for 5 days[1] |
Synonyms | Lanreotide acetate (108736-35-2 free base), BIM 23014 (acetate), BIM 23014 acetate |
Molecular Weight | 1096.33 |
Formula | C54H69N11O10S2 |
CAS No. | 2378114-72-6 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 22.5 mg/mL (19.46 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Lanreotide acetate 2378114-72-6 Others Lanreotide acetate (108736-35-2 free base) Lanreotide BIM 23014 (acetate) inhibit hormone Lanreotide Acetate apoptosis BIM23014 Acetate pituitary BIM 23014 acetate BIM 23014 Acetate Inhibitor 108736-35-2 free base GH3 cells BIM 23014 108736-35-2 tumor BIM23014 BIM-23014 BIM-23014 Acetate adenoma GH-secreting inhibitor